π’Asia-Pac stocks begin mixed following on from the choppy performance stateside where stock markets whipsawed and treasuries rallied in the absence of any hawkish surprise from the US CPI data; ASX 200 (+0.1%), Nikkei 225 (-0.1%), KOSPI
(+0.4%)
π’Stocks Ban In F&O: BHEL, Canara Bank, GNFC, Manappuram
π’ Earnings Today: Ajmera Realty, Alkyl Amines, AsianPaints, BalrampurChini, Bharat Seats, Bliss GVS,CARE Ratings, DCW, Deepak Nitrite, Dr. Lal Path,Eicher, Everest Ind, Gillette India, Gujarat StatePetro, Intellect Design, Mangalore Chemicals,Neuland Lab, Paisalo Digital, PDS, Religare Ent,Siemens, South Indian Bank, Ujjivan Small ZensarTech
π’STOCKS TO WATCH: RVNL, GODREJ CONSUMER,KPI GREEN, GUJRAT GAS, NOVARTIS INDIA,ORCHID PHARMA, H G INFRA, SAGAR CEMENTS,ZYDUS LIFE, RATTANINDIA ENT, PRICOL, L&T, DR.REDDY'S, P&G HYGIENE
(+0.4%)
π’Stocks Ban In F&O: BHEL, Canara Bank, GNFC, Manappuram
π’ Earnings Today: Ajmera Realty, Alkyl Amines, AsianPaints, BalrampurChini, Bharat Seats, Bliss GVS,CARE Ratings, DCW, Deepak Nitrite, Dr. Lal Path,Eicher, Everest Ind, Gillette India, Gujarat StatePetro, Intellect Design, Mangalore Chemicals,Neuland Lab, Paisalo Digital, PDS, Religare Ent,Siemens, South Indian Bank, Ujjivan Small ZensarTech
π’STOCKS TO WATCH: RVNL, GODREJ CONSUMER,KPI GREEN, GUJRAT GAS, NOVARTIS INDIA,ORCHID PHARMA, H G INFRA, SAGAR CEMENTS,ZYDUS LIFE, RATTANINDIA ENT, PRICOL, L&T, DR.REDDY'S, P&G HYGIENE
π₯Rail Vikas Nigam: Co Says Got Letter Of
Acceptance From Mumbai Metropolitan Region
Development Authority Loa For Consortium Of
Co, Siemens India; Cost Of Project 3b Rupees
π₯Godrej Consumer Products: Q4 Cons Net Profit
4.52b Rupees Vs 3.6b (YoY); Est 4.45b | 5.5b (QoQ)
[| Q4 Revenue 32b Rupees Vs 29b (YoY); 35.98b
(QoQ)
π₯KPI Green Energy: Co Says Received The Order
For Execution Of Solar Power Project Of 35 MW
Capacity From Creative Technologies Through Co
Unit M/S. KPIG Energia Pvt Ltd, Under βCaptive
Power Producer (Cpp)' Segment Of The Co
π₯Gujarat Gas: Q4 SI Net Profit 3.69b Rupees Vs
3.7b (QoQ); Est 2.84b | 4.4b (YoY) Q4 Revenue
40.74b Rupees Vs 38.2b (QoQ); 47.7b (YoY) Co
Recommended A Dividend Of 6.65 Rupees Per
Equity Share
π₯Novartis India: Q4 SI Net Profit 250m Rupees Vs
Loss 233m (YoY); Profit 76m (QoQ) Q4 Revenue
761m Rupees Vs 983m (YoY); 802m (QoQ) Co
Recommended A Final Dividend Of 10 Rupees Per
Share And One-Time Special Dividend Of 37.50
Rupees Per Share
π₯Orchid Pharma: Q4 Cons Net Profit 591.4m Rupees
Vs Loss 66m (YoY); Profit 76m (QoQ) Q4 Revenue
2.7b Rupees Vs 1.78b (YoY); 1.6b (QoQ)
π₯H.G. Infra Engineering: Q4 Cons Net Profit 1.71b
Rupees Vs 1b (YoY); 1.3b (QoQ) Q4 Revenue
15.35b Rupees Vs 10.6b (YoY); 11.85b (QoQ)
Co Recommended A Dividend Of 1.25 Rupees Per
Equity Share
π₯Sagar Cements: Q4 Cons Net Profit 1b Rupees
Vs Loss 115.1m (YoY); Loss 220.2m (QoQ) Q4
Revenue 6.21b Rupees Vs 5.02b (YoY); 5.76b (QoQ)
Co Recommended A Dividend Of 0.70 Rupees Per
Equity Share
π₯Zydus Lifesciences: Co Receives EIR For
Pre-Approval Inspection (Pai) At Manufacturing
Facility In Moraiya, Ahmedabad
π₯Ratnamani Metals & Tubes: Q4 Cons Net Profit
1.91b Rupees Vs 1.12b (YoY); 1.33b (QoQ) Q4
Revenue 14.99b Rupees Vs 9.7b (YoY); 10.99b
(QoQ) II Co Recommended A Dividend Of 12
Rupees Per Share
π₯Rattanindia Enterprises: Co Approved Raising Of
Fund To Raise Funds Up To 10b Rupees
π₯Pricol: Q4 Cons Net Profit 298m Rupees Vs 131m
(YoY); 268m (QoQ) Q4 Revenue 5.09b Rupees Vs
4b (YoY); 4.58b (QoQ)
π₯L&T: Q4 Cons Net Profit 39.87b Rupees Vs 36.21b
(YoY); Est 41.75b | 25.53b (QoQ) Q4 Revenue
583b Rupees Vs 528b (YoY); 464b (QoQ) Co
Recommended A Dividend Of 24 Rupees Per Share
π₯Dr. Reddy's Lab: Q4 Cons Net Profit 9.60b Rupees
Vs 970m (YoY); Est 11.45b | 12.5b (QoQ) Q4
Revenue 63.15b Rupees Vs 54.75b (YoY); 67.90b
(QoQ) II Co Recommended A Dividend Of 40 Rupees Per Share
π₯Procter & Gamble Hygiene & Health Care: Q4 S| Net
Profit 1.65b Rupees Vs 1.03b (YoY); 2.07b (QoQ)
[| Q4 Revenue 8.83b Rupees Vs 9.7b (YoY); 11.37b
(QoQ)
Acceptance From Mumbai Metropolitan Region
Development Authority Loa For Consortium Of
Co, Siemens India; Cost Of Project 3b Rupees
π₯Godrej Consumer Products: Q4 Cons Net Profit
4.52b Rupees Vs 3.6b (YoY); Est 4.45b | 5.5b (QoQ)
[| Q4 Revenue 32b Rupees Vs 29b (YoY); 35.98b
(QoQ)
π₯KPI Green Energy: Co Says Received The Order
For Execution Of Solar Power Project Of 35 MW
Capacity From Creative Technologies Through Co
Unit M/S. KPIG Energia Pvt Ltd, Under βCaptive
Power Producer (Cpp)' Segment Of The Co
π₯Gujarat Gas: Q4 SI Net Profit 3.69b Rupees Vs
3.7b (QoQ); Est 2.84b | 4.4b (YoY) Q4 Revenue
40.74b Rupees Vs 38.2b (QoQ); 47.7b (YoY) Co
Recommended A Dividend Of 6.65 Rupees Per
Equity Share
π₯Novartis India: Q4 SI Net Profit 250m Rupees Vs
Loss 233m (YoY); Profit 76m (QoQ) Q4 Revenue
761m Rupees Vs 983m (YoY); 802m (QoQ) Co
Recommended A Final Dividend Of 10 Rupees Per
Share And One-Time Special Dividend Of 37.50
Rupees Per Share
π₯Orchid Pharma: Q4 Cons Net Profit 591.4m Rupees
Vs Loss 66m (YoY); Profit 76m (QoQ) Q4 Revenue
2.7b Rupees Vs 1.78b (YoY); 1.6b (QoQ)
π₯H.G. Infra Engineering: Q4 Cons Net Profit 1.71b
Rupees Vs 1b (YoY); 1.3b (QoQ) Q4 Revenue
15.35b Rupees Vs 10.6b (YoY); 11.85b (QoQ)
Co Recommended A Dividend Of 1.25 Rupees Per
Equity Share
π₯Sagar Cements: Q4 Cons Net Profit 1b Rupees
Vs Loss 115.1m (YoY); Loss 220.2m (QoQ) Q4
Revenue 6.21b Rupees Vs 5.02b (YoY); 5.76b (QoQ)
Co Recommended A Dividend Of 0.70 Rupees Per
Equity Share
π₯Zydus Lifesciences: Co Receives EIR For
Pre-Approval Inspection (Pai) At Manufacturing
Facility In Moraiya, Ahmedabad
π₯Ratnamani Metals & Tubes: Q4 Cons Net Profit
1.91b Rupees Vs 1.12b (YoY); 1.33b (QoQ) Q4
Revenue 14.99b Rupees Vs 9.7b (YoY); 10.99b
(QoQ) II Co Recommended A Dividend Of 12
Rupees Per Share
π₯Rattanindia Enterprises: Co Approved Raising Of
Fund To Raise Funds Up To 10b Rupees
π₯Pricol: Q4 Cons Net Profit 298m Rupees Vs 131m
(YoY); 268m (QoQ) Q4 Revenue 5.09b Rupees Vs
4b (YoY); 4.58b (QoQ)
π₯L&T: Q4 Cons Net Profit 39.87b Rupees Vs 36.21b
(YoY); Est 41.75b | 25.53b (QoQ) Q4 Revenue
583b Rupees Vs 528b (YoY); 464b (QoQ) Co
Recommended A Dividend Of 24 Rupees Per Share
π₯Dr. Reddy's Lab: Q4 Cons Net Profit 9.60b Rupees
Vs 970m (YoY); Est 11.45b | 12.5b (QoQ) Q4
Revenue 63.15b Rupees Vs 54.75b (YoY); 67.90b
(QoQ) II Co Recommended A Dividend Of 40 Rupees Per Share
π₯Procter & Gamble Hygiene & Health Care: Q4 S| Net
Profit 1.65b Rupees Vs 1.03b (YoY); 2.07b (QoQ)
[| Q4 Revenue 8.83b Rupees Vs 9.7b (YoY); 11.37b
(QoQ)
Chart Commando
https://www.youtube.com/live/cjCmRpb0SqA?feature=share
Very Important session for Big learning & earning........ π
Live Trading for free......for all of you at 9.00 Am
Must add reminder........
Live Trading for free......for all of you at 9.00 Am
Must add reminder........
Max pain nifty- at 18300
Max pain BankNifty- at 43500
.....
So nothing any trade seen in market.....
Already market at Max pain , so I am not coming LIve
Max pain BankNifty- at 43500
.....
So nothing any trade seen in market.....
Already market at Max pain , so I am not coming LIve
Dear Commandos,
To watch Important Learning Video, Click on The Link Bellow. π
https://youtube.com/shorts/gaN99vPmj2I?feature=share
To watch Important Learning Video, Click on The Link Bellow. π
https://youtube.com/shorts/gaN99vPmj2I?feature=share